Corticosteroids
Corticosteroids – commonly called “steroids” – are synthetic versions of the hormone cortisol, produced by your adrenal glands. They have potent anti-inflammatory and immunosuppressive effects. Common examples include prednisone, methylprednisolone, and dexamethasone.
Key Takeaways
Steroids are fast-acting and powerful: They provide rapid relief in flares, joint injections, or severe inflammation.
Used in emergencies: Vision-threatening iritis, lupus flares, or vasculitis can require steroids to save organs or life.
Bridge therapy: Steroids allows time for slower medications to take effect.
Side effects escalate with dose and duration: Short-term use is relatively safe; long-term use carries serious risks.
Bone health is a major concern: Up to 40% of long-term users develop osteoporosis.
Infection risk is real: Steroids double the chance of serious infections.
Tapering is essential: Stopping suddenly can cause adrenal crisis.
Quality of life vs. risk trade-off: For many, short bursts are transformative; prolonged courses are damaging.
Not a cure: Steroids treat symptoms but not the inflammatory process itself.
Taking the lowest effective dose for the shortest possible time is the guiding principle.
Steroids for Inflammation
How Steroids Work & Why They Are Used
Corticosteroids (such as prednisone, prednisolone, methylprednisolone, dexamethasone) are synthetic versions of the bodies stress hormone – cortisol, which is normally produced by the adrenal glands. Corticosteroids suppress immune activity by reducing the number and function of immune cells and blocking inflammatory mediators like cytokines, prostaglandins, and leukotrienes.
In arthritis care, steroids are valued for their speed and effectiveness, making them essential in several situations:
Short-term flare control: Oral or injected steroids can reduce swelling and pain within hours to days.
Joint injections (intra-articular use): Deliver high local doses into inflamed joints, often lasting weeks to months.
Ocular inflammation (iritis and uveitis): Used in drops, injections, or oral form to prevent blindness in sight-threatening eye inflammation.
Bridge therapy: Provides relief while waiting for disease-modifying antirheumatic drugs (DMARDs) or biologics to take effect (which may take 8–12 weeks).
- In my experience I would recommend concurrently doing everything you can to manage and reduce inflammation by modifiable factors described on this site. Getting to the root causes of your inflammation and not causing side effects is the strongest path to health and happiness.
Corticosteroid use is widespread worldwide. In high-income countries, between 3 to 10% of adults are prescribed oral steroids in a given year, most commonly for arthritis, asthma, and autoimmune conditions.
Benefits of Corticosteroids
When used appropriately, corticosteroids can be life-saving or function-saving. Benefits include:
Rapid symptom relief: In clinical trials, patients report up to 70–80% improvement in pain and swelling within the first week of oral prednisone.
Protection against joint damage: In severe rheumatoid arthritis (RA) flares, steroids help prevent irreversible cartilage and bone injury.
Vision preservation: In iritis, systemic or ocular steroids can reduce the risk of vision loss by over 60% when treated early.
Short-term functional improvement: Studies show steroid joint injections improve mobility and reduce pain scores for 4–12 weeks, particularly in osteoarthritis and RA.
Emergency use: In systemic lupus erythematosus (SLE) or vasculitis flares, high-dose steroids can prevent organ failure and reduce mortality.
Side Effects & Risks
While powerful, corticosteroids carry some of the highest risks of any arthritis therapy when used long term. The adverse effects are well documented:
Common Short-Term Effects (days to weeks)
Fluid retention, weight gain (up to 2–4 kg in a month)
Insomnia, anxiety, mood swings
Elevated blood sugar (around 20% of patients develop steroid-induced hyperglycaemia during short courses)
Increased appetite
Long-Term Complications (months to years)
Osteoporosis: Up to 40% of long-term steroid users develop significant bone loss or fractures.
Diabetes: Risk increases by 30–40% after 1–2 years of continuous use.
Hypertension: Present in over 50% of chronic users.
Adrenal suppression: After >3 weeks of therapy, the adrenal glands may stop producing cortisol, requiring careful tapering to prevent adrenal crisis.
Infection risk: Moderate-to-high doses double the risk of infections like pneumonia and shingles.
Ocular disease: Long-term use raises the risk of cataracts by 20–40% and glaucoma by 25%.
Psychiatric effects: Around 5–10% of patients develop severe psychiatric side effects, including psychosis.
Avascular necrosis: Rare but serious, often affecting the hip; seen in about 3–4% of chronic users.
Limitations of Corticosteroids
They treat symptoms, not the underlying cause of arthritis.
Long-term use leads to dependency, where reducing the dose causes flares.
They are not considered sustainable for disease control compared to D-MARDs or biologics.
Even at “safe” low doses (less than 5 mg prednisone daily), studies show a doubling of fracture risk and increased cardiovascular disease rates.
The Role of Lifestyle and Root Causes
Steroids do not address the drivers of inflammation, such as poor diet quality, dietary triggers, environmental toxins, excess body fat, gut imbalance, chronic stress, or physical inactivity. These remain the root causes that determine disease progression. While steroids provide a critical short-term bridge, long-term remission usually requires deeper changes in medical management and lifestyle choices.
References
National Institute for Health and Care Excellence (NICE). Corticosteroids for inflammatory arthritis.
Australian Rheumatology Association. Glucocorticoid use in arthritis – patient fact sheet.
Mayo Clinic. Prednisone and other corticosteroids: Balance the risks and benefits.
van Staa TP, et al. Use of oral corticosteroids in the United Kingdom. QJM. 2000;93(2):105–111.
Fardet L, et al. Prevalence and risk factors for corticosteroid side effects: a meta-analysis. PLoS Med. 2007.
Kirwan JR, et al. The effect of glucocorticoids on joint damage in rheumatoid arthritis. NEJM. 1995;333:142–146.
Jorge AM, et al. Glucocorticoid use, osteoporosis, and fracture risk in rheumatoid arthritis. Arthritis Care Res. 2018;70(4):561–568.
Jabs DA, et al. Treatment of uveitis with corticosteroids and immunosuppressive drugs. Am J Ophthalmol. 2000.
Huscher D, et al. Dose-related patterns of glucocorticoid-induced side effects. Arthritis Rheum. 2009;60(11):3112–3117.
Dixon WG, et al. Infections and glucocorticoid therapy in rheumatoid arthritis. Arthritis Rheum. 2011;63(3):633–639.
